Oxford Instruments reiterates FY guidance.


Manufacturing and research company Oxford Instruments reaffirmed its full‑year guidance on Thursday, with adjusted operating profits expected to be in line with market forecasts of £70.2m to £73.0m.

  • Oxford Instruments
  • 15 January 2026 07:19:51
Oxford Instruments

Source: Sharecast

Oxford Instruments reported further progress in its imaging and analysis division, where order intake rose 2.4% on an organic constant currency basis. It also said the division's year‑to‑date book‑to‑bill ratio stands at 1.1, with cost‑reduction measures completed in the first half at its Belfast imaging unit delivering the anticipated benefits in the second half.

The FTSE 250-listed firm said its advanced technologies unit continued to see strong momentum, with year‑to‑date orders up 44.5% OCC, and its order book now offering visibility well into FY27.

At group level, Oxford Instruments said its year‑to‑date book‑to‑bill ratio was 1.2, and stated it was continuing to book and ship new imaging and analysis orders in the fourth quarter, while also focusing on executing its existing order book across both divisions.

Oxford Instruments added that the sale of its NanoScience business had completed on 2 January, generating net cash proceeds of £48.5m after final working‑capital and other adjustments.

Reporting by Iain Gilbert at Sharecast.com


Exchange: London Stock Exchange
Sell:
0.00
Buy:
0.00
Change: 109.54 ( 0.48 %)
Date:
Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.